Disseminated Intravascular Coagulation in Sepsis and Associated Factors

被引:2
作者
Rinaldi, Ikhwan [1 ,2 ]
Sudaryo, Mondastri Korib [1 ]
Prihartono, Nurhayati Adnan [1 ]
机构
[1] Univ Indonesia, Fac Publ Hlth, Dept Epidemiol, Depok 16424, Indonesia
[2] Univ Indonesia, Cipto Mangunkusumo Natl Gen Hosp, Fac Med, Dept Internal Med,Div Hematol & Med Oncol, Jakarta 10430, Indonesia
关键词
sepsis; DIC; coagulation; infection; COAGULOPATHY; MORTALITY;
D O I
10.3390/jcm11216480
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: sepsis is a life-threatening organ dysfunction caused by an excessive host immunological response to infection. The incidence of sepsis is increasing every year, and sepsis is the primary cause of mortality in intensive care units (ICUs). DIC is a coagulopathy syndrome that causes microvascular and macrovascular thrombosis and increases the risk of bleeding due to consumptive coagulopathy. The pathophysiology of DIC in sepsis is complex, and further research is required to investigate the involved mechanisms and risk factors. Method: this study is a prognostic analysis of a retrospective cohort. Samples were patients diagnosed with sepsis and admitted to Cipto Mangunkusumo National General Hospital from January 2016 to October 2022. Research subjects were followed until occurrence of DIC during sepsis or recovery from sepsis. The research subjects were selected from medical records using a consecutive total sampling approach. The inclusion criteria were patients aged >= 18 years old and diagnosed with sepsis according to qSOFA criteria with a score of 2. The exclusion criterion was an incomplete medical record. Bivariate and multivariate logistic regression analyses were performed to determine which independent variables contributed to the incidence of DIC and obtain the odds ratios (ORs). p < 0.05 was considered to indicate a statistically significant difference. Results: a total of 248 patients were included after considering the inclusion and exclusion criteria. Of these, 50 (20.2%) septic patients developed DIC. In the multivariate analysis, albumin <= 2.5 g/dL (OR: 2.363; 95% CI: 1.201-4.649), respiratory infection (OR: 2.414; 95% CI: 1.046-5.571), and antibiotic treatment >= 1 h (OR: 2.181; 95% CI: 1.014-4.689) were associated with DIC development. On the basis of the ROC curve, the area under the curve (AUC) was determined to be 0.705 with 95% CI = (0.631-0.778). Conclusion: in our study, the prevalence of DIC in septic patients was 20.2%. Low albumin, respiratory infection, and antibiotic treatment >= 1 h were found to be risk factors for development of DIC in septic patients.
引用
收藏
页数:13
相关论文
共 38 条
[1]   Sepsis with liver dysfunction and coagulopathy predicts an inflammatory pattern of macrophage activation [J].
Anderko, Renee R. ;
Gomez, Hernando ;
Canna, Scott W. ;
Shakoory, Bita ;
Angus, Derek C. ;
Yealy, Donald M. ;
Huang, David T. ;
Kellum, John A. ;
Carcillo, Joseph A. .
INTENSIVE CARE MEDICINE EXPERIMENTAL, 2022, 10 (01)
[2]   Sepsis-associated disseminated intravascular coagulation and its differential diagnoses [J].
Ba, Toshiaki ;
Watanabe, Eizo ;
Umemura, Yutaka ;
Wada, Takeshi ;
Hayashida, Kei ;
Kushimoto, Shigeki ;
Wada, Hideo .
JOURNAL OF INTENSIVE CARE, 2019, 7 (1)
[3]   Disseminated intravascular coagulation in liver cirrhosis: Fact or fiction? [J].
Ben-Ari, Z ;
Osman, E ;
Hutton, RA ;
Burroughs, AK .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (10) :2977-2982
[4]   DISSEMINATED INTRAVASCULAR COAGULATION IN CIRRHOSIS [J].
CARR, JM .
HEPATOLOGY, 1989, 10 (01) :103-110
[5]   Disseminated intravascular coagulation in non-Hodgkin lymphoma [J].
Chi, SungGi ;
Ikezoe, Takayuki .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2015, 102 (04) :413-419
[6]   Incidence, trends, and outcomes of infection sites among hospitalizations of sepsis: A nationwide study [J].
Chou, Eric H. ;
Mann, Shaynna ;
Hsu, Tzu-Chun ;
Hsu, Wan-Ting ;
Liu, Carolyn Chia-Yu ;
Bhakta, Toral ;
Hassani, Dahlia M. ;
Lee, Chien-Chang .
PLOS ONE, 2020, 15 (01)
[7]   Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation [J].
Dhainaut, JF ;
Yan, SB ;
Joyce, DE ;
Pettilä, V ;
Basson, B ;
Brandt, JT ;
Sundin, DP ;
Levi, M .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (11) :1924-1933
[8]   Comparison of a new criteria for sepsis-induced coagulopathy and International Society on Thrombosis and Haemostasis disseminated intravascular coagulation score in critically ill patients with sepsis 3.0: a retrospective study [J].
Ding, Renyu ;
Wang, Zhong ;
Lin, Yuan ;
Liu, Baoyan ;
Zhang, Zhidan ;
Ma, Xiaochun .
BLOOD COAGULATION & FIBRINOLYSIS, 2018, 29 (06) :551-558
[9]   Sepsis and septic shock: Guideline-based management [J].
Dugar, Siddharth ;
Choudhary, Chirag ;
Duggal, Abhijit .
CLEVELAND CLINIC JOURNAL OF MEDICINE, 2020, 87 (01) :53-64
[10]  
Evans L, 2021, INTENS CARE MED, V47, P1181, DOI [10.1007/s00134-021-06506-y, 10.1097/CCM.0000000000005337]